Network officials also said voters should expect more of a Koch focus on grassroots activism throughout the 2020 election cycle.Politicsread more
Stores are extending hours and cities are spending on light shows as China tries to encourage consumers to spend more money at night.China Economyread more
Stocks in Asia Pacific edged up in Friday morning trade as a series of developments overnight on the U.S.-China trade front dampened hopes.Asia Marketsread more
GM's usage of temporary workers, potential closure of plants and health care contributions remain major sticking points, according to people familiar with the talks.Autosread more
Gunfire erupted on the streets of Washington, D.C., on Thursday night and at least several people were shot, local media reported.U.S. Newsread more
In a room full of avowed capitalists, policies that sound to some like socialism are bound not to go over well.Delivering Alpharead more
Trump has criticized Facebook numerous times since becoming president, most recently posting on Twitter that the company's proposed digital currency, libra, will "have little...Technologyread more
Republicans and Democrats have long since separated themselves by ideology, leaving each more uniformly conservative or liberal than ever. And now a new data analysis by the...Politicsread more
Asian cities are on the rise and are dominant in the Fintech space.Financeread more
At least in terms of monetary policy, Pence says should be taking after other regions who keep their benchmark interest rates near zero.Delivering Alpharead more
The Pentagon on Thursday said the recent attack on Saudi Arabian oil facilities were "sophisticated" and represented a "dramatic escalation" in tensions within the region.Defenseread more
Check out which companies are making headlines before the bell:
Royal Dutch Shell—Shell will buy BG Group for $70 billion in cash and stock. This is the first major oil company takeover deal since Chevron bought Texaco for $36 billion in 2000.
Tesla—The automaker announced an upgrade of its flagship Model S, featuring a larger battery pack and all-wheel drive.
Merck—Merck received a "Breakthrough Therapy" designation from the FDA for its investigational hepatitis C therapy.
Apple—Societe Generale downgraded Apple to "hold" from "buy," saying currency issues and difficult comparisons for handset sales could weigh on Apple shares.
Lululemon—Sterne Agee upgraded the yogawear maker's stock to "buy" from "neutral," saying investments in new systems and processes will pay off sooner and more than anticipated.
WebMD—Goldman downgraded the health website operator's shares to "sell" from "neutral," citing reduced opportunity for outperformance.
Rite Aid—The drug store chain earned an adjusted 14 cents per share for its latest quarter, doubling estimates, with revenue also above consensus. However, the company did give a full-year consensus below current Street estimates.
Xerox—Citi upgraded Xerox to "buy" from "neutral," pointing to a compelling valuation and increased opportunity for accretive acquisition deals.
Noble Energy—The oil and gas exploration and production company will cut about 220 positions, about half at Noble's Colorado operations.
Dave & Buster's—The entertainment venue operator reported adjusted quarterly profit of 33 cents per share, 5 cents above estimates, with the restaurant chain's revenue beating estimates as well. Revenue guidance was, however, on the conservative side.
Lionsgate—The entertainment company announced a secondary offering which will see MHR Fund Management sell 10 million common shares in the movie studio. Lionsgate will not receive any proceeds from the offering.
Pentair—The industrial manufacturing company cut fiscal first quarter guidance due to a stronger dollar, and slower than expected oil and gas industry shipments.
Mattress Firm—The mattress retailer said certain shareholders would sell more than 1.5 million shares of its common stock, including some members of management and the board of directors. The company won't receive any proceeds from the sale.
Rio Tinto—Australia's treasurer reportedly said he would not allow Britain's Glencore to buy the mining company, because of concerns over losing Rio's considerable tax revenue. Glencore had approached Rio last year but was rebuffed.
Novo Nordisk—The Danish drug maker was told by the FDA that the agency had accepted Novo's resubmitted application for its insulin drug Tresiba. The drug had originally been rejected by the FDA two years ago.
Dollar Tree—The Federal Trade Commission told Dollar Tree that it must divest 340 stores before it can complete its $8.5 billion takeover of rival discount retailer Family Dollar Stores. Dollar Tree said it expects almost all of those divested stores to be current Family Dollar locations.
Questions? Comments? Email us at email@example.com